Shigella, NIAID category B pathogens, cause ~550 million cases of diarrhea or dysentery and 1.1 million deaths each year. Shigella infections are characterized by the induction of acute inflammation associated with a massive recruitment of neutrophils to the colon resulting in subsequent massive tissue destruction. Despite this impressive host response, Shigella survive in this harsh environment, primarily by invading and spreading between colonic epithelial cells. Shigella survival is primarily due to the ability of ths pathogen to directly usurp and regulate host cell processes through the activity of ~30 type 3 effectors, proteins that the bacteria directly injects into the host cell cytosol through its highl conserved type 3 secretion system. The Shigella type 3 secretion system is essential for all steps in Shigella pathogenesis including their invasion of host cells, escape from the phagosome, intracellular and intercellular spread and inhibition of the production of pro-inflammatory cytokines. The overall goal of our research is to understand how Shigella effectors enable this pathogen to evade and suppress host innate immune responses. Specifically we propose to determine the host cell proteins and or processes targeted by type 3 effectors that we have established to be involved in Shigella phagosomal escape and cell-to-cell, two steps in Shigella pathogenesis that are relatively poorly understood. These studies should prove general insights regarding the spread of intracellular bacterial pathogens. We also propose to identify host cell proteins directed ubiquitinated and targeted for degradation by Shigella effectors as these proteins are likely key elements in signaling pathways involved in normally inducing host innate immune defenses that normally act to combat bacterial pathogens. By performing and completing the proposed aims, we expect to greatly expand our understanding of how Shigella and other intracellular pathogens manipulate host cell processes in order to evade host innate immune defenses. This information will have the potential to guide the development of novel therapeutics to prevent and treat infections caused by Shigella and other bacterial pathogens.
Shigella is a human bacterial pathogen that causes a severe diarrhea associated with a significant degree of morbidity and mortality. Our application is aimed at understanding how Shigella utilize virulence proteins to directly manipulate epithelial cells to promote their survival and dissemination by evading host innate immune defenses. The results our studies could lead to the development of novel therapeutics for the prevention and treatment of Shigella and potentially other bacterial pathogens by improving our understanding of how bacteria manipulate host cells.
|González-Prieto, Coral; Lesser, Cammie F (2017) Rationale redesign of type III secretion systems: toward the development of non-pathogenic E. coli for in vivo delivery of therapeutic payloads. Curr Opin Microbiol 41:1-7|
|Piro, Anthony S; Hernandez, Dulcemaria; Luoma, Sarah et al. (2017) Detection of Cytosolic Shigella flexneri via a C-Terminal Triple-Arginine Motif of GBP1 Inhibits Actin-Based Motility. MBio 8:|
|Du, Juan; Reeves, Analise Z; Klein, Jessica A et al. (2016) The type III secretion system apparatus determines the intracellular niche of bacterial pathogens. Proc Natl Acad Sci U S A 113:4794-9|
|Sheehan, Kathy B; Martin, MaryAnn; Lesser, Cammie F et al. (2016) Identification and Characterization of a Candidate Wolbachia pipientis Type IV Effector That Interacts with the Actin Cytoskeleton. MBio 7:|
|Janakiraman, Anuradha; Lesser, Cammie F (2016) How to manage stress: Lessons from an intracellular pathogen. Virulence :1-3|
|Reeves, Analise Z; Lesser, Cammie F (2016) Transfer of Large Contiguous DNA Fragments onto a Low Copy Plasmid or into the Bacterial Chromosome. Bio Protoc 6:|
|Reeves, Analise Z; Spears, William E; Du, Juan et al. (2015) Engineering Escherichia coli into a protein delivery system for mammalian cells. ACS Synth Biol 4:644-54|
|Costa, Sonia C P; Lesser, Cammie F (2014) A multifunctional region of the Shigella type 3 effector IpgB1 is important for secretion from bacteria and membrane targeting in eukaryotic cells. PLoS One 9:e93461|
|Costa, Sonia C P; Schmitz, Alexa M; Jahufar, Fathima F et al. (2012) A new means to identify type 3 secreted effectors: functionally interchangeable class IB chaperones recognize a conserved sequence. MBio 3:|
|de Groot, Jens C; Schlüter, Kai; Carius, Yvonne et al. (2011) Structural basis for complex formation between human IRSp53 and the translocated intimin receptor Tir of enterohemorrhagic E. coli. Structure 19:1294-306|
Showing the most recent 10 out of 17 publications